# Portal Vein Thrombosis > Portal vein thrombosis for NEET-PG Medicine: cirrhotic and non-cirrhotic causes, anticoagulation timing, portal cavernoma and variceal management. - Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/portal-vein-thrombosis-medical - Exam / course: NEET-PG · Subject: Medicine - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Portal Vein Thrombosis", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/portal-vein-thrombosis-medical ## Direct answer A twenty-five-year-old with a first variceal bleed and a soft, normal-sized liver points the workup away from cirrhosis and toward the portal vein itself — portal vein thrombosis. Acute PVT presents with pain, fever and ileus and is treated with early anticoagulation, which recanalises the vein in a large proportion of patients when started promptly. Chronic PVT matures into a portal cavernoma — a spongy mesh of collaterals — producing portal hypertension with a liver that still works, managed like variceal disease but with an anticoagulation decision layered on top. ## What you must remember - **Two clinical worlds:** acute PVT (abdominal pain, fever, ileus, early ascites) versus chronic PVT/portal cavernoma (varices, splenomegaly, hypersplenism — with preserved liver function). - **Causes:** cirrhosis is the leading overall cause; in non-cirrhotic patients — myeloproliferative neoplasms (JAK2), antiphospholipid syndrome, PNH; local factors — omphalitis or umbilical vein catheterisation in the neonatal period (a common Indian legacy of adult cavernoma), pyogenic liver abscess, abdominal tuberculosis lymphadenitis, pancreatitis, cholecystitis, post-splenectomy; always exclude HCC invasion. - **Diagnosis:** contrast-enhanced CT in the portal venous phase — a filling defect in the portal vein; cavernous transformation and varices define chronicity; Doppler is the bedside first look. - **Acute PVT treatment:** start anticoagulation early — LMWH then a vitamin K antagonist, target INR 2–3; recanalisation is achievable in roughly 40% or more when treatment begins within weeks, and falls with delay. - **The bleeding paradox:** recent variceal bleeding is not a permanent contraindication — band the varices first, then anticoagulate; bleeding risk must be weighed against the recanalisation window. - **Chronic PVT/cavernoma:** screen and band varices, add non-selective beta-blockers; anticoagulation is favoured when a prothrombotic factor is identified, thrombosis is recent or recurrent, or extension is progressing. - **Surgery and TIPS:** reserved for refractory variceal bleeding or progressive thrombosis; transplantation applies when cirrhosis coexists. - **Lifelong nuance:** anticoagulating a cavernoma reopened nothing years ago — the decision there is about preventing extension and recurrence, not recanalisation. ## The neonatal scar that surfaces at twenty-five A 25-year-old man vomits blood; endoscopy shows oesophageal varices; his liver is smooth and normal-sized, albumin 4.0 g/dL, INR 1.0, and CT reveals a portal cavernoma devouring the porta hepatis. His mother recalls neonatal sepsis with umbilical sepsis in the first week of life — the omphalitis story that explains everything three decades later, the vein thrombosed in infancy, recanalised never, collaterals flowering into the cavernoma. The management sequence is the learning payload. First, control the bleed: band the varices now. Second, decide about anticoagulation: with no cirrhosis, no prothrombotic factor after a JAK2 and thrombophilia screen, and a thrombosis that is decades old, the argument for anticoagulation is weak — there is no recanalisation window left to exploit; but had his cavernoma been fresh or extending, or a JAK2 mutation surfaced, anticoagulation would be the correct answer despite the varices, preceded by banding. Third, the long game: non-selective beta-blockade, repeat endoscopy until varices are eradicated, and vigilance for hypersplenism and biliary symptoms — cavernoma compressing the bile duct (portal cavernous cholangiopathy) is a favourite long-case finding. His liver, the examiner stresses, is innocent; every decision is about veins, not hepatocytes. ## The anticoagulation dilemma The viva question that defines this topic: "Would you anticoagulate a patient who just bled from varices because of portal vein thrombosis?" The examiner wants the structured answer — band the varices first, then anticoagulate early in acute PVT, because the recanalisation window is measured in weeks and a re-thrombosed vein rarely reopens; the old fear of bleeding is now weighed against data showing anticoagulation does not meaningfully worsen variceal haemorrhage once endoscopic control is achieved. The second trap is chronological: candidates apply acute-phase logic (recanalisation) to chronic cavernoma, where the vein is beyond rescue — there the goal narrows to preventing propagation, which changes the threshold for treatment. Third, always name HCC: cirrhosis with new PVT demands a CT evaluation for tumour thrombus before anyone calls it bland — and tumour thrombus, not anticoagulation, is the next move there. ## Frequently asked questions ### Why does anticoagulation have to be early in acute portal vein thrombosis? Recanalisation rates of roughly 40% or more fall sharply with delay, because organised thrombus rarely reopens — the treatment window is weeks, not months. ### Is variceal bleeding a contraindication to anticoagulation? No — varices are banded first and anticoagulation then proceeds in acute PVT, balancing bleeding risk against the recanalisation window. ### What is a portal cavernoma? The network of collateral channels replacing an occluded portal vein in chronic PVT — causing portal hypertension with preserved liver function. ### Which neonatal events cause adult portal cavernoma? Omphalitis and umbilical vein catheterisation thrombosing the portal vein in infancy — a classical Indian textbook association. ### What must be excluded in a cirrhotic with new portal vein thrombosis? Hepatocellular carcinoma with tumour thrombus — imaging and alpha-fetoprotein before attributing the clot to decompensation alone.